Back to Search Start Over

Glenmark Pharmaceuticals' arm receives USFDA's approval for Fingolimod Capsules.

Source :
Ace Analyser: Company News; 6/19/2020, pN.PAG-N.PAG, 1p
Publication Year :
2020

Abstract

The Gilenya Capsules, 0.5 mg market achieved annual sales of approximately $2.1 billion [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
FINGOLIMOD
DRUGS
SALES
MARKETS

Details

Language :
English
Database :
Complementary Index
Journal :
Ace Analyser: Company News
Publication Type :
Report
Accession number :
143850603